The Frontier Psychiatrists...LIVE! May 5th, 2024
It's called Rapid Acting Mental Health Treatment NYC, and you are invited
I know what you are thinking. Satirical and data-driven newsletters are AMAZING…but they also are not very communal. Readers peruse this newsletter daily. I don’t…see my friends while reading it. I don’t interact with the industry leaders I’m reading about in real-time. This seems like a hard-to-surmount problem for a newsletter. Here at The Frontier Psychiatrists, however, we have anticipated the ache in your heart. We have prepared an answer. It’s called Rapid Acting Mental Health Treatment. It’s a series of conferences. One has already happened, this January, in San Fransisco. The Next? It’s in NYC….In the middle of the American Psychiatric Association Annual Meeting 2024 time frame. It’s free for APA members, but it is also open to the public.
Yes. I know. It’s exciting. It’s a live-action newsletter event…I promise it’s every bit as exciting as you imagine from that description.
I also understand—Imagination may vary. We will have guests well beyond your author. Perhaps you are interested in the future of psychedelic medicine? Well, we have you covered.
Ben Everett, Ph.D. from Lykos Theraputics will be there. They used to be known as MAPS, PBC. Much like Prince, they did a rebrand. No, they can’t say anything that will screw up their FDA review process. It will be the most appropriately boundried conversation of all time. We respect the regulatory process around these parts.
Maybe you want to understand how AI will transform psychiatric care?
We also have you covered. Dominik Middelmann mdhub.ai —helping physicians get their notes done—will be in the same room as Brett Talbot, Ph.D. from Videra Health—measuring outcomes with video capture AI models. Hot Damn!
Perhaps you want to understand how real-world evidence might impact the future of the FDA approval for novel interventions? Between Osmind’s CMO
and iRxReminder’s COO Fred Ma, M.D. on the same stage, we all might learn something.Maybe you want to understand how digital therapeutics guided by AI got to market in the first place? Well, conference Co-Founder Grady Hannah of Nightware will be chatting with
author Michelle Bernabe, R.N., about that very topic.Maybe you’ve wondered if you were “ADHD?” It’s hard to focus, I will grant you, a remarkable array of speakers. We can ask Colin Kealey, M.D. of Neurosigma, and he may demure to answer if you aren’t in the cohort of children 7-12 for whom his device is FDA-approved.
And if all of this is stressing you out, learn about sympathetic nervous system biology from James Lynch, M.D., the founder of the Stellate Institute. It’s going to be a banger. SGB is a rapid acting treatment for PTSD.
Get your tickets now!
Also, you can spread the word.
Looking forward to speaking and moderating and mingling!